Log In
Print
BCIQ
Print
Print this Print this
 

Tamiflu, oseltamivir

Also known as: GS 4104, Ro 64-0796

  Manage Alerts
Collapse Summary General Information
Company Gilead Sciences Inc.
DescriptionNeuraminidase inhibitor
Molecular Target Neuraminidase
Mechanism of ActionNeuraminidase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationInfluenza virus
Indication DetailsPrevent influenza infection; Treat and prevent H1N1 influenza in infants under 1 year of age; Treat and prevent H1N1 influenza in pregnant and breastfeeding women; Treat and prevent influenza; Treat and prevent influenza A and B strains; Treat and prevent influenza in children; Treat and prevent swine influenza A (H1N1); Treat avian influenza A (H5N1) infection; Treat influenza; Treat influenza in adults at risk for complications; Treat influenza in children and adults and prevent influenza in adolescents and adults; Treat influenza infection
Regulatory Designation

Partner

Chugai Pharmaceutical Co. Ltd.; Roche


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today